相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines
Erica Gentilin et al.
REPRODUCTIVE TOXICOLOGY (2014)
Management of adrenal cancer: a 2013 update
M. Terzolo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Maternal Exposure to Dioxin Imprints Sexual Immaturity of the Pups through Fixing the Status of the Reduced Expression of Hypothalamic Gonadotropin-Releasing Hormone
Tomoki Takeda et al.
MOLECULAR PHARMACOLOGY (2014)
The Effect of Opioid Therapy on Endocrine Function
Michael J. Brennan
AMERICAN JOURNAL OF MEDICINE (2013)
The hypothalamic-pituitary-gonadal axis is target of cadmium toxicity. An update of recent studies and potential therapeutic approaches
Anunciacion Lafuente
FOOD AND CHEMICAL TOXICOLOGY (2013)
Kinase Inhibitors: Adverse Effects Related to the Endocrine System
Maya B. Lodish
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Central Diabetes Insipidus: A Previously Unreported Side Effect of Temozolomide
Alexander T. Faje et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Salvatore Maria Corsello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function
Erica Gentilin et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Male pubertal development: are endocrine-disrupting compounds shifting the norms?
William Zawatski et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Effects of non-steroidal anti-inflammatory drugs on hormones and genes of the hypothalamic-pituitary-gonad axis, and reproduction of zebrafish
Kyunghee Ji et al.
JOURNAL OF HAZARDOUS MATERIALS (2013)
Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing's syndrome
Roberta Giordano et al.
PITUITARY (2013)
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion
Teresa Gagliano et al.
PITUITARY (2013)
Inappropriate Elevation of Serum Thyrotropin Levels in Patients Treated with Axitinib
Kenji Ohba et al.
THYROID (2013)
ASSOCIATION OF IPILIMUMAB THERAPY FOR ADVANCED MELANOMA WITH SECONDARY ADRENAL INSUFFICIENCY: A CASE SERIES
Le Min et al.
ENDOCRINE PRACTICE (2012)
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Camille Baudry et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
The Insults of Illicit Drug Use on Male Fertility
Carolyn M. Fronczak et al.
JOURNAL OF ANDROLOGY (2012)
Tyrosine Kinase Inhibitors Noncompetitively Inhibit MCT8-Mediated Iodothyronine Transport
Doreen Braun et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Hyponatremia associated with Ipilimumab-induced hypophysitis
Zachary R. Barnard et al.
MEDICAL ONCOLOGY (2012)
Anti-VEGF therapy in pituitary carcinoma
Leon D. Ortiz et al.
PITUITARY (2012)
Imatinib has adverse effect on growth in children with chronic myeloid leukemia
Deepak Bansal et al.
PEDIATRIC BLOOD & CANCER (2012)
Thyroid Adverse Effects of Psychotropic Drugs: A Review
Rami Bou Khalil et al.
CLINICAL NEUROPHARMACOLOGY (2011)
In Vivo Evidence for Epidermal Growth Factor Receptor (EGFR)-mediated Release of Prolactin from the Pituitary Gland
Maik Dahlhoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Hidenori Fukuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Antidepressants recruit new neurons to improve stress response regulation
A. Surget et al.
MOLECULAR PSYCHIATRY (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Drug-induced endocrine disorders in the intensive care unit
Zachariah Thomas et al.
CRITICAL CARE MEDICINE (2010)
Therapeutic Concentrations of Mitotane (o,p '-DDD) Inhibit Thyrotroph Cell Viability and TSH Expression and Secretion in a Mouse Cell Line Model
Maria Chiara Zatelli et al.
ENDOCRINOLOGY (2010)
Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice
Willem Heydendael et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction?
O. Bilgir et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans
R. Berardelli et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes
Troy Dillard et al.
PITUITARY (2010)
Interferon-β treatment associated with a biochemical profile suggestive of acromegaly. A case report of a patient treated for multiple sclerosis
Mikkel Andreassen et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?
L. Kebapcilar et al.
MEDICAL PRINCIPLES AND PRACTICE (2009)
Potential role of type I interferons in the treatment of pituitary adenomas
Giovanni Vitale et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Imatinib
Konstantinos Liapis et al.
ANNALS OF PHARMACOTHERAPY (2008)
Pituitary apoplexy during induction chemotherapy for acute myeloid leukaemia
L. Silberstein et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Fulvia Daffara et al.
ENDOCRINE-RELATED CANCER (2008)
Side effects of anabolic androgenic steroids abuse
A. Bonetti et al.
INTERNATIONAL JOURNAL OF SPORTS MEDICINE (2008)
Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor
M. Haap et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
Adjuvant mitotane treatment for adrenocortical carcinoma
Massimo Terzolo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects
Wendy M. Golden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Cytotoxic T-Lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer
JA Blansfield et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis
JD Mikkelsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Alemtuzumab-induced syndrome of inappropriate anti-diuretic hormone
JS Kunz et al.
LEUKEMIA & LYMPHOMA (2005)
Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment
E Rota et al.
PSYCHIATRY RESEARCH (2005)
HPA axis activation in major depression and response to fluoxetine: a pilot study
EA Young et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Environmental cadmium exposure, adverse effects and preventive measures in Japan
K Nogawa et al.
BIOMETALS (2004)
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy
L Capuron et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN
M Benavides et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Diazepam increases the hypothalamic-pituitary-adrenocorticaI (HPA) axis activity by a cyclic AMP-dependent mechanism
ML Vargas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Treating depression with selective serotonin reuptake inhibitors: A practical approach
SM Sampson
MAYO CLINIC PROCEEDINGS (2001)
Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine
WJ Inder et al.
PSYCHOPHARMACOLOGY (2001)
Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders
SR Tollin
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2000)
New drugs in psychiatry
JF Goldberg
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA (2000)
分享论文
